-
HLB Pep targets India in exclusive peptide deal with Bioserve Biotechnologies
06 Aug 2025 05:09 GMT
… with Indian biotechnology company Bioserve Biotechnologies, setting the … of Japanese regenerative medicine company Reprocell and … In May, its desmopressin active pharmaceutical ingredient (API), used … FDA inspection next year for ganirelix, an infertility drug …
-
FDA news in pediatrics: July 2025
01 Aug 2025 17:08 GMT
… Pharmaceuticals’ New Drug Application for ET-600, an oral liquid formulation of desmopressin … four phase 3 trials in the ICONIC … reduce reliance on medical formula and improve … FDA approved pegcetacoplan (Empaveli; Apellis Pharmaceuticals) as the first treatment …
-
Glenmark Pharmaceuticals Limited - 708270 - 07/11/2025
22 Jul 2025 14:19 GMT
… and Drug Administration (FDA) inspected your drug manufacturing facility, Glenmark Pharmaceuticals Limited … parameters to ensure effective remediations for the dissolution failures … testing of your desmopressin acetate tablets.
Glenmark Pharmaceuticals Inc., ( …
-
Eton Pharmaceuticals Announces FDA Acceptance of New Drug Application for ET-600 (Desmopressin Oral Solution)
08 Jul 2025 10:50 GMT
… the U.S. Food and Drug Administration (FDA) and has been assigned … Sean Brynjelsen, CEO of Eton Pharmaceuticals. “ET-600 represents yet another … proprietary formulation of desmopressin oral solution developed for the treatment of central …
-
FDA accepts NDA for ET-600, desmopressin oral solution for pediatric AVP deficiency
08 Jul 2025 17:21 GMT
… dosing accuracy associated with current treatment options.
“We are thrilled … in the United States. Treatment requires careful titration to manage … Pharmaceuticals. Eton Pharmaceuticals Announces FDA Acceptance of New Drug Application for ET-600 (Desmopressin …
-
Von Willebrand Disease: Clinical And Preclinical Studies, Leading Companies, Therapeutic Evaluation, Emerging Treatments, Treatment Strategies, And Pipeline Overview Vega Therapeutics, Hemab
24 Jun 2025 02:33 GMT
… permanent cure, treatments such as desmopressin and clotting factor … requires a thorough medical history along with … treatment.
In December 2023, the US Food and Drug Administration (FDA … Willebrand Disease Clinical Trials and advancements
Von Willebrand …
-
Nocturnal Enuresis Medication Market Forecast 2025-2034: Insights on Size, Growth, Trends & Competition
19 Jun 2025 11:19 GMT
… remote diagnosis and treatment, and better accessibility to medications.
Which Major … & Co. KG, Ferring Pharmaceuticals A/S, UroGen Pharma …
- By Drug Class: Desmopressin, Imipramine, Oxybutynin, Combined Pharmacotherapy, Antidepressants
- By …
-
FDA Approves Eton Pharma's Oral Drug For Adrenal Insufficiency In Pediatric Patients, Analyst Sees Boost In 2025 Revenue
29 May 2025 17:10 GMT
… .S. Food and Drug Administration (FDA) approved Eton Pharmaceuticals, Inc.’s ETON new … : Eton Pharma Plans FDA Filing For ET-600 Oral Desmopressin Next Month … designed to help patients access treatment. Eton Cares will offer co …
-
FDA approves Eton’s application for hydrocortisone oral solution
29 May 2025 13:34 GMT
… US Food and Drug Administration (FDA) approval as a … struggle with swallowing pills or have specific … FDA-approved hydrocortisone treatment for paediatric adrenocortical insufficiency.
Eton Pharmaceuticals … Office for the desmopressin oral solution formulation …
-
Brain Delivery Strategies for Biomacromolecular Drugs: Intranasal Administration
22 May 2025 15:04 GMT
… medications (ASMs) have been developed for epilepsy treatment.133 However, these drugs … peptides such as desmopressin, calcitonin and enkephalin … Artif Cells Nanomed Biotechnol. 2018;46(8):2088– … “”“Nose-to-Brain” drug delivery. Pharmaceutics. 2019;11(2):84. …